Agreed, flight100! With working capital to cover the next 9 months (as per the interim filings), warrants of $.45 and $.60, a Venowave agreement amounting to $10 million annually, a serum test to meet the demands of determining immunity post vaccination and the need for a test like AcuVid to bring "normalcy" back to developing nations while they wait up to two years to be vaccinated
...more